Key facts
- Our Belux head office is located in Braine-l'Alleud
- BMS has been active in Belgium and Luxembourg for more than 40 years
- Every day, our people work together to make a difference in the lives of patients suffering from serious diseases
- Through more than 114 active clinical trials with more than 1,150 patients, we ensure that Belgian and Luxembourg patients have access to the most innovative new medicines
We continue to invest and develop our pipeline, and we are the leader in a number of new indications.
Historical overview of reimbursed medicines in Belgium
BMS Worldwide
Update 2021
Chief Executive Officer:
Headquarters:
New York City
Business:
Biopharmaceuticals
Website:
NYSE Listing:
BMY
Net Global Sales:
$42.5 billion in 2020
R&D Investment:
$11.14 billion which included the discovery and development of new medicines for patients
Principal Locations:
BMS in Belgium
Update 2021
General Manager:
Sally Ann McNab
Local Headquarters:
Parc de l’Alliance
Avenue de Finlande 4
1420 Braine-l’Alleud
Avenue de Finlande 4
1420 Braine-l’Alleud
Key Therapeutic Areas:
Oncology
Hematology
Cardiovascular
Immunology